Does SIPONIMOD Cause Product packaging quantity issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product packaging quantity issue have been filed in association with SIPONIMOD (MAYZENT). This represents 0.1% of all adverse event reports for SIPONIMOD.
6
Reports of Product packaging quantity issue with SIPONIMOD
0.1%
of all SIPONIMOD reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From SIPONIMOD?
Of the 6 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIPONIMOD. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SIPONIMOD Cause?
Fatigue (958)
Headache (862)
Dizziness (654)
Gait disturbance (506)
Multiple sclerosis relapse (504)
Fall (478)
Multiple sclerosis (455)
Lymphocyte count decreased (398)
Nausea (397)
Drug ineffective (396)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which SIPONIMOD Alternatives Have Lower Product packaging quantity issue Risk?
SIPONIMOD vs SIPULEUCEL-T
SIPONIMOD vs SIROLIMUS
SIPONIMOD vs SIRUKUMAB
SIPONIMOD vs SITAGLIPTIN
SIPONIMOD vs SKYLA